Netherlands· NL-0afe8a7db606

Eskazole 400 mg tabletten

A albendazole product containing albendazol, registered in Netherlands by GlaxoSmithKline B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC P02CA03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about albendazolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Albendazole is registered in 10 of 19 countries.

Countries holding a registration under ATC P02CA03 (albendazole), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search albendazole products by name

Albendazole · ATC P02CA03

10 / 19 countries

Czechiaprice
Franceprice
Germany
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of albendazole costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $5.63 in France to $36.54 in Switzerland — a ×6.5 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Albendazole · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

CH Switzerland$36.54
FR France$5.63

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ALBENDAZOL
Manufacturer: GlaxoSmithKline B.V.
Country: Netherlands (NL)
ATC code: P02CA03
ATC class: Albendazole
Defined daily dose: 0.8 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
15437

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

114 interactions on record for albendazole.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check albendazole against other medicines How interaction checks work

Albendazole · interactions on record

114 records

3 severe
102 moderate
9 minor

Most severe, free to view

CladribineL01BB04severe
CladribineL04AA40severe
ClozapineN05AH02severe
AprepitantA04AD12moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Albendazole in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All albendazole products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

Austria · Eskazole
Bulgaria · Зентел
Cyprus · Zestaval
Germany · Albendazol Micro Labs, Eskazole
Spain · Eskazole
France · Eskazole, Zentel
United Kingdom (Northern Ireland) · Albendazole Brown & Burk Uk
Greece · Albendol
Hungary · Albendazol Pharma Vim
Italy · Zentel
Luxembourg · Albendazol Micro Labs
Malta · Zestaval
Poland · Zentel
Portugal · Zentel
Romania · Albendazol Vim Spectrum, Duador
Slovakia · Zentel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/960cf4aa-ae93-471a-93af-794c592697d2
GET /v1/drugs/960cf4aa-ae93-471a-93af-794c592697d2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h15437_smpc.pdf",
  "strength": null,
  "atc_label": "Albendazole",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg15437",
  "excipients": [
    "BENZYLALCOHOL (E 1519)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "LACTOSE 0-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MALTODEXTRINE",
    "MALTODEXTRINE",
    "MALTODEXTRINE",
    "MAÏSZETMEEL",
    "NATRIUMLAURILSULFAAT",
    "PASSIEVRUCHTSMAAKSTOF",
    "POVIDON K 30 (E 1201)",
    "SACCHAROIDE NATRIUM X-WATER (E 954)",
    "SINAASAPPELSMAAKSTOF",
    "VANILLESMAAKSTOF",
    "ZONNEGEEL FCF ALUMINIUMLAK (E 110)"
  ],
  "substances": [
    "ALBENDAZOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h15437.pdf",
  "authorised_at": "1992/11/03",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "15437",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about albendazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console